Combatting Substandard and Falsified Medicines: Public Awareness and Identification of Counterfeit Medications

被引:7
|
作者
El-Dahiyat, Faris [1 ]
Fahelelbom, Khairi M. S. [1 ]
Jairoun, Ammar Abdulrahman [2 ]
Al-Hemyari, Sabaa Saleh [3 ]
机构
[1] Al Ain Univ, Coll Pharm, Al Ain, U Arab Emirates
[2] Dubai Municipal, Hlth & Safety Dept, Dubai, U Arab Emirates
[3] Emirates Hlth Serv Estab, Pharm Dept, Dubai, U Arab Emirates
关键词
falsified mediation; counterfeit medications; knowledge-attitude-behavior; identification; public awareness; DRUGS; INDUSTRY;
D O I
10.3389/fpubh.2021.754279
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objectives: The objective of this study was to determine the identification rate of substandard and falsified medications and its association with knowledge among public. Methods: This descriptive cross-sectional study was conducted in different geographic areas among a convenient sample of people aged 18 or older. A validated web-based electronic questionnaire was used for data collection tool. The questionnaire contained three sections assessing the following: (1) Sociodemographic data; (2) Knowledge regarding counterfeit medicines; and (3) Ability to identify counterfeit medicines, according to 12 questions rated on a five-point Likert scale. Univariate and multivariate logistic regression analyses were used to assess the association between sociodemographic factors and counterfeit medication identification rate. Results: A total of 320 people participated in the study. Only 98 participants (30.6%, 95% CI 25.6-35.7%) identified the counterfeit medications. Ability to correctly identify counterfeit medications was significantly higher in participants who were older (p = 0.016), single (p = 0.001), Asian (p = 0.001), or American (p = 0.019), as well as those who indicated that they would check the certification of the medications (p = 0.015) and report counterfeit medications to the authorities (p < 0.0001). Conclusions: These results underscore the need for greater public awareness of the hazards associated with counterfeit medicines.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Combatting Substandard and Falsified Medicines: A View from Rwanda
    Binagwaho, Agnes
    Bate, Roger
    Gasana, Michel
    Karema, Corine
    Mucyo, Yves
    Mwesigye, John Patrick
    Biziyaremye, Floribert
    Nutt, Cameron T.
    Wagner, Claire M.
    Jensen, Paul
    Attaran, Amir
    [J]. PLOS MEDICINE, 2013, 10 (07)
  • [2] Dermatologic Consequences of Substandard, Spurious, Falsely Labeled, Falsified, and Counterfeit Medications
    Schwartzman, Gabrielle H.
    Dekker, Paige K.
    Silverstein, Anna S.
    Fontecilla, Natalia M.
    Norton, Scott A.
    [J]. DERMATOLOGIC CLINICS, 2022, 40 (02) : 227 - 236
  • [3] Substandard and falsified medicines
    不详
    [J]. BULLETIN OF THE WORLD HEALTH ORGANIZATION, 2018, 96 (01) : 4 - 5
  • [4] Dangers of Substandard or Falsified Medicines
    Friedrich, M. J.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 319 (03): : 219 - 219
  • [5] Substandard and Falsified Medicines in Myanmar
    Sakuda, Mirai
    Yoshida, Naoko
    Takaoka, Takashi
    Sanada, Tomoko
    Rahman, Mohammad Sofiqur
    Tanimoto, Tsuyoshi
    Zin, Theingi
    Kimura, Kazuko
    Tsuboi, Hirohito
    [J]. PHARMACY, 2020, 8 (01)
  • [7] A cross-sectional analysis of falsified, counterfeit and substandard medicines in a low-middle income country
    Khurelbat, Daariimaa
    Dorj, Gereltuya
    Sunderland, Bruce
    Sanjjav, Tsetsegmaa
    Bayarsaikhan, Enkhtuul
    Damdinjav, Davaadagva
    Dorj, Gantuya
    Jigjidsuren, Altantuya
    Lkhagvasuren, Oyun
    Erdenetsetseg, Baasandorj
    [J]. BMC PUBLIC HEALTH, 2020, 20 (01)
  • [8] Counterfeit and falsified medicines, alert the patient
    Guerriaud, Mathieu
    [J]. ACTUALITES PHARMACEUTIQUES, 2018, 57 (580): : 1 - 1
  • [9] Fighting the fakes: tackling substandard and falsified medicines
    Oksana Zirka Pyzik
    Ibrahim Abubakar
    [J]. Nature Reviews Disease Primers, 8
  • [10] Stemming the Global Trade in Falsified and Substandard Medicines
    Gostin, Lawrence O.
    Buckley, Gillian J.
    Kelley, Patrick W.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 309 (16): : 1693 - 1694